Centessa Pharmaceuticals plc ADR’s filing revealed that its President, Orexin Program Accardi Mario Alberto unloaded Company’s shares for reported $0.2 million on Oct 27 ’25. In the deal valued at $25.00 per share,8,000 shares were sold. As a result of this transaction, Accardi Mario Alberto now holds 194,394 shares worth roughly $4.38 million.
Then, Accardi Mario Alberto bought 8,000 shares, generating $200,000 in total proceeds.
Before that, HUSSAIN IQBAL J sold 6,000 shares. Centessa Pharmaceuticals plc ADR shares valued at $134,439 were divested by the General Counsel at a price of $22.41 per share. As a result of the transaction, HUSSAIN IQBAL J now holds 105,386 shares, worth roughly $2.38 million.
Stephens initiated its Centessa Pharmaceuticals plc ADR [CNTA] rating to an Overweight in a research note published on October 28, 2025; the price target was $35. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in early September with a ‘”an Overweight”‘ rating. Truist started covering the stock on July 21, 2025. It rated CNTA as “a Buy”.
Price Performance Review of CNTA
On Tuesday, Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] saw its stock jump 0.94% to $22.54. Over the last five days, the stock has lost -5.05%. Centessa Pharmaceuticals plc ADR shares have risen nearly 39.65% since the year began. Nevertheless, the stocks have risen 34.57% over the past one year. While a 52-week high of $25.42 was reached on 11/03/25, a 52-week low of $9.60 was recorded on 04/09/25.
Levels Of Support And Resistance For CNTA Stock
The 24-hour chart illustrates a support level at 22.09, which if violated will result in even more drops to 21.64. On the upside, there is a resistance level at 23.03. A further resistance level may holdings at 23.52.
How much short interest is there in Centessa Pharmaceuticals plc ADR?
A steep rise in short interest was recorded in Centessa Pharmaceuticals plc ADR stocks on 2025-10-31, growing by 0.16 million shares to a total of 5.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 4.99 million shares. There was a rise of 3.14%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 28, 2025 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $35 price target.
